1. Home
  2. PTIX vs CYN Comparison

PTIX vs CYN Comparison

Compare PTIX & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • CYN
  • Stock Information
  • Founded
  • PTIX 1994
  • CYN 2013
  • Country
  • PTIX United States
  • CYN United States
  • Employees
  • PTIX N/A
  • CYN N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • CYN EDP Services
  • Sector
  • PTIX Health Care
  • CYN Technology
  • Exchange
  • PTIX Nasdaq
  • CYN Nasdaq
  • Market Cap
  • PTIX 2.0M
  • CYN 2.2M
  • IPO Year
  • PTIX 2016
  • CYN 2021
  • Fundamental
  • Price
  • PTIX $0.27
  • CYN $7.76
  • Analyst Decision
  • PTIX
  • CYN
  • Analyst Count
  • PTIX 0
  • CYN 0
  • Target Price
  • PTIX N/A
  • CYN N/A
  • AVG Volume (30 Days)
  • PTIX 599.7K
  • CYN 1.8M
  • Earning Date
  • PTIX 03-31-2025
  • CYN 03-05-2025
  • Dividend Yield
  • PTIX N/A
  • CYN N/A
  • EPS Growth
  • PTIX N/A
  • CYN N/A
  • EPS
  • PTIX N/A
  • CYN N/A
  • Revenue
  • PTIX N/A
  • CYN $102,118.00
  • Revenue This Year
  • PTIX N/A
  • CYN $18.11
  • Revenue Next Year
  • PTIX N/A
  • CYN $198.58
  • P/E Ratio
  • PTIX N/A
  • CYN N/A
  • Revenue Growth
  • PTIX N/A
  • CYN N/A
  • 52 Week Low
  • PTIX $0.25
  • CYN $6.70
  • 52 Week High
  • PTIX $1.87
  • CYN $3,885.00
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 34.94
  • CYN 26.09
  • Support Level
  • PTIX $0.25
  • CYN $8.55
  • Resistance Level
  • PTIX $0.30
  • CYN $43.35
  • Average True Range (ATR)
  • PTIX 0.03
  • CYN 6.47
  • MACD
  • PTIX 0.00
  • CYN 9.88
  • Stochastic Oscillator
  • PTIX 10.43
  • CYN 2.89

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: